Skip to main content
. 2023 Feb 4;24(4):3086. doi: 10.3390/ijms24043086

Figure 7.

Figure 7

Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis regarding mfIHC applications in clinical cancer immunotherapy.